| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |